Shenzhen Reagen Technology Co., Ltd. Is a large-scale biotechnology enterprise that integrates industry-university-research collaboration and combines science, technology, and commerce. It specializes in the R&D, production, sales, and technical services of clinical, food safety, and animal epidemic prevention test reagents. Since its establishment, the company has continuously accelerated technological innovation and the development of its own brands, building core competitive advantages and rapidly enhancing its overall strength. Currently, it has established multiple experimental technology platforms involved in life science research, such as RT-PCR, real-time fluorescent quantitative PCR, ELISA, Western Blot, Southern Blot, confocal microscopy, flow cytometry, HPLC, immunohistochemistry, immunofluorescence, sequencing, and gene chips.

The company serves as the exclusive agent for Abraxis reagent kits in China and the principal distributor for REAGEN in the Chinese market, fully responsible for all operations of Abraxis and REAGEN within China. Additionally, the company places great emphasis on fostering a people-oriented corporate culture and strives to build a harmonious enterprise.

Guided by the business philosophy of "Surviving on Quality, Growing through Service" and committed to "Honest Service, " the company has won the trust and affection of numerous friends. Its products are continuously innovated, and the product structure is constantly adjusted and optimized.

As a vibrant, proactive, and dynamic young enterprise, the company boasts a strong corporate culture, innovative strategic vision, robust scientific research capabilities, and advanced management concepts. It has evolved into a standardized, diversified, and comprehensive modern group company with a full range of products. The company strives to establish excellent relationships with clients and is committed to providing robust support and satisfactory after-sales services in the fields they serve.

With the nation's continuous rapid development, the company is facing favorable opportunities. We express our gratitude to the clinical and research workers on the front lines and sincerely invite you to join us in striving for a brighter tomorrow and creating a glorious future together!